ReP USP - Resultado da busca

Parte de monografia/livro-apres/pref/posf
In recent times, the world faced one... [Prefácio] (2024)
Chatterjee, Shampa; Duarte Neto, Amaro Nunes ; Cascella, Marco; Villapol, Sonia; Viswanathan, Anand; Ganesh, Aravind; Lai, Ching Lung; Remuzzi, Giuseppe
Source: Understanding the pandemic: pathophysiology, transmission and treatment of COVID-19. Unidade: FM
Subjects: COVID-19, CORONAVIRUS, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Shampa et al. In recent times, the world faced one.. [Prefácio]. Understanding the pandemic: pathophysiology, transmission and treatment of COVID-19. Academic Press: San Diego. . Acesso em: 25 abr. 2026. , 2024
APA
Chatterjee, S., Duarte Neto, A. N., Cascella, M., Villapol, S., Viswanathan, A., Ganesh, A., et al. (2024). In recent times, the world faced one.. [Prefácio]. Understanding the pandemic: pathophysiology, transmission and treatment of COVID-19. Academic Press: San Diego.
NLM
Chatterjee S, Duarte Neto AN, Cascella M, Villapol S, Viswanathan A, Ganesh A, Lai CL, Remuzzi G. In recent times, the world faced one.. [Prefácio]. Understanding the pandemic: pathophysiology, transmission and treatment of COVID-19. 2024 ;[citado 2026 abr. 25 ]
Vancouver
Chatterjee S, Duarte Neto AN, Cascella M, Villapol S, Viswanathan A, Ganesh A, Lai CL, Remuzzi G. In recent times, the world faced one.. [Prefácio]. Understanding the pandemic: pathophysiology, transmission and treatment of COVID-19. 2024 ;[citado 2026 abr. 25 ]
Monografia/livro
Understanding the pandemic: patophysiology, transmission, and treatment of COVID-19 (2024)
Chatterjee, Shampa; Duarte Neto, Amaro Nunes ; Cascella, Marco; Villapol, Sonia; Viswanathan, Anand; Ganesh, Aravind; Lai, Ching Lung; Remuzzi, Giuseppe
Unidade: FM
Subjects: COVID-19, CORONAVIRUS, PANDEMIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Shampa et al. Understanding the pandemic: patophysiology, transmission, and treatment of COVID-19. . Academic Press: San Diego. . Acesso em: 25 abr. 2026. , 2024
APA
Chatterjee, S., Duarte Neto, A. N., Cascella, M., Villapol, S., Viswanathan, A., Ganesh, A., et al. (2024). Understanding the pandemic: patophysiology, transmission, and treatment of COVID-19. Academic Press: San Diego.
NLM
Chatterjee S, Duarte Neto AN, Cascella M, Villapol S, Viswanathan A, Ganesh A, Lai CL, Remuzzi G. Understanding the pandemic: patophysiology, transmission, and treatment of COVID-19. 2024 ;[citado 2026 abr. 25 ]
Vancouver
Chatterjee S, Duarte Neto AN, Cascella M, Villapol S, Viswanathan A, Ganesh A, Lai CL, Remuzzi G. Understanding the pandemic: patophysiology, transmission, and treatment of COVID-19. 2024 ;[citado 2026 abr. 25 ]
Artigo de periodico
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease (2019)
Charytan, David M; Solomon, Scott D; Ivanovich, Peter; Remuzzi, Giuseppe; Cooper, Mark E; Mcgill, Janet B; Parving, Hans-Henrik; Parfrey, Patrick; Singh, Ajay K; Burdmann, Emmanuel de Almeida
Source: Diabetes obesity & metabolism. Unidade: FM
Subjects: DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, INSUFICIÊNCIA RENAL CRÔNICA, METFORMINA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARYTAN, David M et al. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes obesity & metabolism, v. 21, n. 5, p. 1199-1208, 2019Tradução . . Disponível em: https://doi.org/10.1111/dom.13642. Acesso em: 25 abr. 2026.
APA
Charytan, D. M., Solomon, S. D., Ivanovich, P., Remuzzi, G., Cooper, M. E., Mcgill, J. B., et al. (2019). Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes obesity & metabolism, 21( 5), 1199-1208. doi:10.1111/dom.13642
NLM
Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, Mcgill JB, Parving H-H, Parfrey P, Singh AK, Burdmann E de A. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease [Internet]. Diabetes obesity & metabolism. 2019 ; 21( 5): 1199-1208.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1111/dom.13642
Vancouver
Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, Mcgill JB, Parving H-H, Parfrey P, Singh AK, Burdmann E de A. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease [Internet]. Diabetes obesity & metabolism. 2019 ; 21( 5): 1199-1208.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1111/dom.13642
Artigo de periodico
Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial (2017)
Causland, Finnian R. Mc; Claggett, Brian; Pfeffer, Marc A; Burdmann, Emmanuel de Almeida; Eckardt, Kai-Uwe; Levey, Andrew S; McMurray, John J. V; Remuzzi, Giuseppe; Singh, Ajay K; Solomon, Scott D; Toto, Robert D; Parfrey, Patrick
Source: American journal of nephrology. Unidade: FM
Subjects: HEMOGLOBINAS, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL CRÔNICA, DIABETES MELLITUS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAUSLAND, Finnian R. Mc et al. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. American journal of nephrology, v. 46, n. 6, p. 488-497, 2017Tradução . . Disponível em: https://doi.org/10.1159/000485326. Acesso em: 25 abr. 2026.
APA
Causland, F. R. M., Claggett, B., Pfeffer, M. A., Burdmann, E. de A., Eckardt, K. -U., Levey, A. S., et al. (2017). Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. American journal of nephrology, 46( 6), 488-497. doi:10.1159/000485326
NLM
Causland FRM, Claggett B, Pfeffer MA, Burdmann E de A, Eckardt K-U, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial [Internet]. American journal of nephrology. 2017 ; 46( 6): 488-497.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1159/000485326
Vancouver
Causland FRM, Claggett B, Pfeffer MA, Burdmann E de A, Eckardt K-U, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial [Internet]. American journal of nephrology. 2017 ; 46( 6): 488-497.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1159/000485326
Artigo de periodico
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study (2016)
Mehta, Ravindra L.; Burdmann, Emmanuel A.; Cerdá, Jorge; Feehally, John; Fredric Finkelstein,; García-García, Guillermo; Godin, Melanie; Jha, Vivekanand; Lameire, Norbert H.; Levin, Nathan W.; Lewington, Andrew; Lombardi, Raúl; Macedo, Etienne; Rocco, Michael; Aronoff-Spencer, Eliah; Tonelli, Marcello; Zhang, Jing; Remuzzi, Giuseppe
Source: Lancet. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL, ESTUDOS MULTICÊNTRICOS, FATORES DE RISCO, SINAIS E SINTOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Ravindra L. et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet, v. 387, n. 10032, p. 2017-2025, 2016Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(16)30240-9. Acesso em: 25 abr. 2026.
APA
Mehta, R. L., Burdmann, E. A., Cerdá, J., Feehally, J., Fredric Finkelstein,, García-García, G., et al. (2016). Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet, 387( 10032), 2017-2025. doi:10.1016/S0140-6736(16)30240-9
NLM
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Fredric Finkelstein, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study [Internet]. Lancet. 2016 ; 387( 10032): 2017-2025.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/S0140-6736(16)30240-9
Vancouver
Mehta RL, Burdmann EA, Cerdá J, Feehally J, Fredric Finkelstein, García-García G, Godin M, Jha V, Lameire NH, Levin NW, Lewington A, Lombardi R, Macedo E, Rocco M, Aronoff-Spencer E, Tonelli M, Zhang J, Remuzzi G. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study [Internet]. Lancet. 2016 ; 387( 10032): 2017-2025.[citado 2026 abr. 25 ] Available from: https://doi.org/10.1016/S0140-6736(16)30240-9

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em